Results for technologies (5)
Advanced filter
Novel Molecules to Activate Immune Pathways (No. T4-2212)
Bacterial and plant immune systems rely on Toll/Interleukin-1 receptor (TIR) domains to detect pathogens and initiate defense responses through immune signals comprising isomers of cyclic ADP-ribose.
Phage therapy: Engineering “super-phages” expressing Tad1 genes to overcome b...
Read more
19371
AI-Driven Discovery Platform for Immune Protein Inhibitors (No. T4-2027)
There is a growing need for innovative strategies to selectively target key drivers of immune-mediated diseases.
Discovery of highly specific protein inhibitors targeting key human immune molecules, enabling the development of novel biologics for autoimmune and inflammatory diseas...
Read more
19381
New Antiviral Drugs from Bacterial Natural Products (No. T4-1934)
There is a growing need for effective antiviral therapies, particularly for viruses that currently lack approved treatments.
Treatment of viral infections with no currently approved antiviral therapies
Development of broad-spectrum antiviral drugs
Nucleotide chain term...
Read more
12514
A Novel Database to Reduce Unsuccessful Cloning in E. Coli by Detection of Toxic Genes (No. M7-1576)
Synthetic genes are commonly used in academic and industrial applications, however in many cases these said genes can be toxic when inserted into the ubiquitously used E. coli. This is problematic as time and money is wasted on attempts to generate genes that will not function in E. coli.
...
Read more
5530
AI-Designed Proteins for Bacterial Domestication (No. T4-2489)
Bacterial defense systems often block plasmid delivery, limiting strain engineering and biomanufacturing.
Enabling efficient transformation of previously untransformable bacterial strains
Increasing plasmid delivery and expression efficiency in industrial hosts
Expanding the genet...
Read more
19375